Trial Profile
Prospective study investigating the adherence to and satisfaction with transdermal rivastigmine treatment as reported by patients and caregivers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Feb 2016
Price :
$35
*
At a glance
- Drugs Rivastigmine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 12 Feb 2016 New trial record